| 1 |
The pathogenesis of early retinal changes of diabetic retinopathy |
|
| | G. B. Arden, S. Sivaprasad | | | Documenta Ophthalmologica. 2012; | | | [HTML Full text] [Google Scholar] | | | 2 |
Treatment of proliferative diabetic retinopathy with anti-VEGF agents |
|
| | Aysha Salam, Raeba Mathew, Sobha Sivaprasad | | | Acta Ophthalmologica. 2011; : no | | | [HTML Full text] [Google Scholar] | | | 3 |
Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy |
|
| | Jardeleza, M.S.R. and Miller, J.W. | | | . 2009; 24(2): 87-92 | | | [Pubmed] [Google Scholar] | | | 4 |
Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study |
|
| | Raquel Costa, Ângela Carneiro, Ana Rocha, Ana Pirraco, Manuel Falcão, Luísa Vasques, Raquel Soares | | | Journal of Cellular Biochemistry. 2009; 108(6): 1410-1417 | | | [Pubmed] [Google Scholar] | | | 5 |
Effects of hydralazine on ocular blood flow and laser-induced choroidal neovascularization |
|
| | Jiang, W., Chiou, G.C.Y. | | | International Journal of Ophthalmology. 2008; 8(12): 2359-2363 | | | [Pubmed] [Google Scholar] | | | 6 |
New VEGF antagonists as possible therapeutic agents in vascular disease |
|
| | Slevin, M., Kumar, P., Wang, Q., Kumar, S., Gaffney, J., Grau-Olivares, M., Krupinski, J. | | | Expert Opinion on Investigational Drugs. 2008; 17(9): 1301-1314 | | | [Pubmed] [Google Scholar] | |
|
